1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Sesen Bio Acquires Viventia Bio

M&A Deal Summary

Sesen Bio Acquires Viventia Bio

On September 21, 2016, Sesen Bio acquired life science company Viventia Bio

Acquisition Highlights
  • This is Sesen Bio’s 1st transaction in the Life Science sector.
  • This is Sesen Bio’s 1st transaction in Canada.
  • This is Sesen Bio’s 1st transaction in Ontario.

M&A Deal Summary
Date 2016-09-21
Target Viventia Bio
Sector Life Science
Buyer(s) Sesen Bio
Deal Type Add-on Acquisition
Advisor(s) Hogan Lovells (Legal)

Target

Viventia Bio

Winnipeg, Ontario, Canada
Viventia Bio, Inc. is a biopharmaceutical company specializing in the discovery and development of a new generation of immunotoxin products offering safer and more beneficial cancer therapies. Viventia Bio was established in 1983 and is headquartered in Winnipeg, Manitoba.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sesen Bio

Cambridge, Massachusetts, United States
Category Company
Founded 2008
Sector Life Science
Employees27
Revenue 40M USD (2022)
DESCRIPTION

Sesen is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics (TPTs). Eleven Sesen Bio was founded in 2008 and is based in Cambridge, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal